|
Despite EUA Revocations, Monoclonal Antibodies Beneficial for COVID Patients
|
|
Because of in vitro evidence that they were not effective against newer SARS-cOv-2 strains, monoclonal antibodies (mAbs) lost their FDA emergency use authorization (EUA) for the treatment of high-risk COVID-19 outpatients with mild-to-moderate infection. Find out why the authors of a new study suggest that might have been premature and that mAbs appear to still be beneficial.
|
|
|
Personalized Blood Pressure Treatment More Effective Than Fixed Choice?
|
|
|
Many clinical guidelines are pushing more personalized medicine and patient choice in a general way. But, specifically, does personalizing blood pressure medication—as opposed to using a fixed choice—increase effectiveness? A new randomized, double-blind study published in the Journal of the American Medical Association study suggests that is the case. Here is more information.
|
|
Statin So Beneficial for HIV Patients That Large Trial Was Halted
|
|
|
The findings of a new large-scale study that was halted for efficacy are likely to be practice-changing for HIV patients. Pharmacists should be aware that the REPRIEVE study found participants who took pitavastatin calcium daily reduced their risk of major adverse cardiovascular events by 35% compared with those receiving a placebo. Here are more details.
|
|
|
Adults Prescribed Stimulants for ADHD Increased During COVID Pandemic
|
|
Pharmacists are well aware of the ongoing shortage of Adderall, its generics, and other stimulants used to treat attention-deficit/hyperactivity disorder (ADHD). What they might not realize, however, is how much increased demand appears to have played a role. Find out how much stimulant prescriptions for adults increased before and during the COVID-19 pandemic.
|
|
.jpg)
